Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2002-12-20
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia and South Africa. The aim of this trial is to compare the
efficacy and safety of repaglinide plus insulin NPH (insulin Neutral Protamine Hagedorn) with
insulin NPH alone in subjects with type 2 diabetes inadequately controlled on repaglinide.